22. もやもや病 Moyamoya disease Clinical trials / Disease details
臨床試験数 : 14 / 薬物数 : 21 - (DrugBank : 14) / 標的遺伝子数 : 28 - 標的パスウェイ数 : 44
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR1900027197 | 2019-05-01 | 2019-11-04 | Study on the protective effect of desflurane combined with propofol on the brain of patients with moyamoya disease undergoing cerebral revascularization | Study for the protective effect of desflurane on the brain of patients with moyamoya disease | Moyamoya disease | Group D:Desflurane for anesthesia maintenance;GroupP:Propofol;GroupPD:Desflurane and propofol; | The First Affiliated Hospital of Zhengzhou University | NULL | Completed | 20 | 65 | Both | Group D:30;GroupP:30;GroupPD:30; | Phase 4 | China |